"Health" Supplements Send 23,000 to Emergency Rooms in the U.S Each Year

 

More than 20 percent of these patients are children under the age of five  October 15, 2015 By Gene Emery NEW YORK (Reuters Health) - Dietary supplements send 23,000 people, many of them children, to the emergency room in the U.S. each year, according to a new estimate. Just over 9% require hospitalization. Many patients report heart symptoms. The supplements include herbal products, amino acids, vitamins, minerals, and other complementary nutrition products hawked for a wide range of uses, often with little or no testing to back up claims. The new study "illustrates the idea that something that's 'natural' is not necessarily safe, and these products do not come without risk," Dr. Curtis Haas, director of pharmacy for the University of Rochester Medical Center and a past president of the American College of Clinical Pharmacy, told Reuters Health. He was not involved in the research. But a trade association that represents supplement manufacturers, the Council for Responsible Nutrition, reacted with a statement arguing that the results "reinforce that dietary supplements are safe products, particularly when put into the context with the number of people - over 150 million Americans - who take dietary supplements every year." Congress has thwarted attempts to strictly regulate the $14.8 billion industry. The new study, released online October 14 in the New England Journal of Medicine, was based on a federal database of adverse events reported at 63 hospitals over a 10-year period. At these hospitals, the research team identified 3,667 emergency room visits linked to the supplements. That extrapolates to 23,005 adverse events nationwide each year, including an estimated 2,154 hospitalizations. Unsupervised children under age 5 accounted for 21.6% of the visits. Chief author Dr. Andrew Geller of the Centers for Disease Control and Prevention in Atlanta, Georgia told Reuters Health the findings suggest that "all medicines and dietary supplements should be stored up and out of sight of children." Adults ages 20 to 34 made up an even bigger proportion of victims - 28%. Weight-loss products accounted for an estimated 3,339 emergency room visits each year by women, nearly three times the number for men. Among males, an estimated 567 visits were attributed to products designed for sexual enhancement and 368 were for body-building products. Comparable numbers for women were so small the researchers couldn't come up with a reliable estimate. Heart symptoms were the chief complaint in 43% of people taking weight-loss products, 46% of patients taking energy products, 50% taking body-building products, and 37% taking sexual-enhancement products. "What's most concerning is the age of people coming in with cardiovascular complications or symptoms," Dr. Haas said. "They are in their 20s to 30s, which shows there are risks to these products." Among older adults, swallowing problems caused nearly 40% of emergency department visits for supplement-related adverse events, with micronutrients implicated in more than 80% of these visits, the researchers said. "The number of emergency department visits attributed to supplement-related adverse events that we identified is probably an underestimation, since supplement use is underreported by patients, and physicians may not identify adverse events associated with supplements as often as they do those associated with pharmaceuticals," the researchers said. The Department of Health and Human Services supported this research.   http://www.scientificamerican.com/article/health-supplements-send-23-000-to-emergency-rooms-in-the-u-s-each-year/?WT.mc_id=SA_WR_20151021

Nanoparticles could boost effectiveness of allergy shots

 

Wed, 10/21/2015 - 10:49am American Chemical Society Whether triggered by cats, bees, pollen or mites, allergies are on the rise. And the bad news doesn’t stop there. The only current therapy that treats their causes is allergen-specific immunotherapy—or allergy shots—which can cause severe side effects. Now, researchers report in Biomacromolecules the development of a potentially better allergy shot that uses nanocarriers to address these unwanted issues. For many people, allergies are a seasonal annoyance. But for others, exposure to a particular allergen can cause adverse reactions such as itching, breathing problems or even death. Allergy shots can reduce sensitivity by slowly ramping up exposure to the offending substance. But because these shots expose the body to the very thing people are allergic to, the treatment itself can sometimes trigger reactions. In order to develop a safer, more direct, cause-based therapy, researchers have developed nanoparticles that envelop an allergen and deliver it to specific cells. But these carriers degrade too slowly, hampering the effectiveness of the treatment. Holger Frey and colleagues set out to overcome these limitations. The researchers designed a new type of nanocarrier based on the biocompatible molecule poly(ethylene glycol), or PEG, that releases its cargo only in targeted immune cells. The nanocarrier degrades when it encounters the acidic part of these cells, simultaneously releasing the allergen and getting rid of the packaging. The researchers say this approach also could be used for vaccines or immunotherapies for other conditions such as cancer or AIDS. Source: American Chemical Society http://www.rdmag.com/news/2015/10/nanoparticles-could-boost-effectiveness-allergy-shots